Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06477692 · ClinicalTrials.gov registry record · Phase 2

Invert-Prospective Phase II Randomized Trial of Involved Nodal Versus Elective Neck RadioTherapy

A Phase 2 study of Head and Neck Cancer, sponsored by University of Texas Southwestern Medical Center.

Recruiting
Registry status
Phase 2
Development phase
80
Enrollment target
1
Study location

NCT06477692 is a Phase 2 study of Head and Neck Cancer that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 80 participants, below the 260-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06477692, a Phase 2 study of Head and Neck Cancer, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.

RECRUITING
Registry status
Phase 2
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

To determine the risk of solitary elective volume recurrence following involved nodal radiotherapy (INRT) versus elective nodal irradiation (ENI)

Conditions Studied

Interventions

  • DRUG ENI using IMRT with or without chemotherapy
  • RADIATION INRT
  • RADIATION ENI

Study Locations (1)

Texas

  • UT Southwestern Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2024-11-14
Est. Completion 2028-07-01
Phase Phase 2

What the Registry Record Tells You About NCT06477692

The ClinicalTrials.gov registry entry for NCT06477692 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 260-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (69% lower). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Head and Neck Cancer appearing as the primary indexed condition, and to 3 interventions - of which ENI using IMRT with or without chemotherapy is the first listed.

NCT06477692 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06477692 about?

NCT06477692 is a clinical study titled "Invert-Prospective Phase II Randomized Trial of Involved Nodal Versus Elective Neck RadioTherapy". To determine the risk of solitary elective volume recurrence following involved nodal radiotherapy (INRT) versus elective nodal irradiation (ENI)

What is the current status of trial NCT06477692?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 80 participants. The study started on 2024-11-14. Estimated completion is 2028-07-01.

What conditions does trial NCT06477692 study?

This clinical trial studies the following conditions: Head and Neck Cancer.

What interventions are being tested in trial NCT06477692?

The interventions under investigation include: ENI using IMRT with or without chemotherapy (DRUG), INRT (RADIATION), ENI (RADIATION).

Who is sponsoring clinical trial NCT06477692?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06477692 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Head and Neck Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.